# Antidepressants Trial in Parkinson's Disease

> **NCT03652870** · PHASE3 · COMPLETED · sponsor: **University College, London** · enrollment: 52 (actual)

## Conditions studied

- Depression
- Parkinson Disease

## Interventions

- **DRUG:** Nortriptyline
- **DRUG:** Escitalopram
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03652870
- **Lead sponsor:** University College, London
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-05
- **Primary completion:** 2023-01-23
- **Final completion:** 2023-04-30
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2023-05-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03652870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03652870, "Antidepressants Trial in Parkinson's Disease". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03652870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*